Sagespring Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Sagespring Wealth Partners's LLY Position: Q2 2026 in Review
Sagespring Wealth Partners increased its Eli Lilly (LLY) stake by 6.5% in Q2 2026, buying an estimated $691K and bringing the position to 11,000 shares worth $13.2M. The position accounts for 0.2% of the portfolio, ranked #66.
Sagespring Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Sagespring Wealth Partners held 11,000 shares of Eli Lilly worth $13.2M as of Q2 2026.
- Sagespring Wealth Partners bought 676 Eli Lilly shares in Q2 2026, an estimated $691K.
- Eli Lilly made up 0.2% of Sagespring Wealth Partners's portfolio in Q2 2026, its #66 holding.
- Sagespring Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.